Stock GOSS GOSSAMER BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Gossamer Bio, Inc.

Equities

GOSS

US38341P1021

Real-time Estimate Cboe BZX
Other stock markets
 18:31:46 14/05/2024 BST 		5-day change 1st Jan Change
0.736 USD +2.22% Intraday chart for Gossamer Bio, Inc. +0.10% -19.76%
05-07 Gossamer Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Chiesi Farmaceutici S.P.A Gossamer Bio, Inc Announces Transformative Global Collaboration to Develop and Commercialize Seralutinib in Pulmonary Arterial Hypertension and Other Respiratory Indications CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GOSS Stock
  4. News Gossamer Bio, Inc.
  5. MarketScreener Editorial Features